These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3967845)

  • 21. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
    Umetsu T; Kato T
    Thromb Haemost; 1978 Feb; 39(1):167-76. PubMed ID: 580491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
    Oblath RW; Buckley FO; Green RM; Schwartz SI; DeWeese JA
    Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
    [No Abstract]   [Full Text] [Related]  

  • 27. Indirect evidence of impairment of platelet desaturase enzymes in diabetes mellitus.
    Jones DB; Carter RD; Mann JI
    Horm Metab Res; 1986 May; 18(5):341-4. PubMed ID: 3013745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
    Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
    Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.
    De la Cruz JP; Moreno A; Muñoz M; García Campos JM; Sánchez de la Cuesta F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):454-9. PubMed ID: 8996228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.
    Frank P; Novak RF
    Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of aspirin and dipyridamole and its derivatives on platelet disaggregation.
    Morris CD; Heslop PA
    Cent Afr J Med; 1977 Nov; 23(11):251-3. PubMed ID: 603896
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.
    Boudreaux MK; Dillon AR; Ravis WR; Sartin EA; Spano JS
    Am J Vet Res; 1991 Dec; 52(12):1992-9. PubMed ID: 1789513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The retired breeder rat as a new model for antiplatelet drug discovery.
    Saunders RN; Burns TS; Stelzer MR; Waskawic ER
    Lab Anim Sci; 1977 Oct; 27(5 Pt 2):757-61. PubMed ID: 592727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of aspirin standard therapy and chronotherapy on circadian organization of hemocoagulation in patients with insulin-dependent diabetes mellitus].
    Zaslavskaia RM; Tulemisov EU; Teĭblium MM
    Klin Med (Mosk); 2002; 80(2):43-6. PubMed ID: 11898722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Platelet aggregation inhibitors. Their possible use in pediatric pathology].
    Zannino L; Salvadori G
    Minerva Pediatr; 1979 Jan; 31(2):153-69. PubMed ID: 379581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.